Genomics Stocks

Jil · February 25, 2021, 7:43pm

I do not have cash and do not want to go over margin now. They released earnings recently, loss more than expected. This may not go up immediately and waiting for my cash release after market is up !

hanera · February 26, 2021, 12:31am

Cathie sold AMZN GOOG AAPL to buy TDOC SQ TSLA

Jil · February 26, 2021, 3:22am

I have cleared some money but that may settle Monday. I have buy TDOC and DCA for CRSP and TWST whatever qty possible by me. None buy and hold but swing trade.

If I can free up some more money tomorrow (if market swings up), that would be nice too!

Elt1 · February 26, 2021, 5:40am

hanera · February 26, 2021, 9:45am

Recently, Cathie is in love with BEAM and EXAS. She has been selling TWST… don’t know whether there is something wrong with the business or just selling high to raise cash.

Jil · March 2, 2021, 4:12pm

Jil:

AMRS is going crazy from $2 to $16 as of now, company is too small 3.5B level, looks like made a break through (claiming) that pulls up to 10B level, hoping (It may also be hype).

If Whatever they said is true, then it may be 3x to 5x level possibilities.

The global acne treatment market was valued at approximately $11 billion in 2019 according to Allied Market Research. North America accounted for the largest share of revenue in 2019. With China as the biggest market, Asia-Pacific is expected to register the highest growth globally over the next five years. Acne or acne vulgaris is one of the most common skin conditions, affecting up to 50 million Americans annually, including approximately 85 percent of people between the ages of 12 and 24. In addition, due to the wearing of face masks to protect against COVID-19 infection, the incidence of “maskne”-related acne has been rising. Maskne is a skin condition caused by wearing a face mask or other covering, symptoms of which can include acne around the nose, cheeks, mouth and chin.

Otherwise, it is risk.

https://finance.yahoo.com/news/amyris-announces-breakthrough-clinical-results-130000214.html

Jil · March 3, 2021, 1:42am

Here is reddit profit using AMRS !!

hanera · March 5, 2021, 4:50pm

Massacre of genomics.

My holdings,
ARKG - 30 shares, very RED.
CRSP - 100 shares, very RED.
NVTA - 200 shares, very RED.
TWST - 100 shares, very RED.
MRNA - very RED.
REGN - very RED. Today is very green?

TDOC - Sold in time.

Elt1 · March 6, 2021, 2:27am

Biotech is a burial ground

Jil · March 6, 2021, 2:48am

Even AAPL got hit 17% not because of AAPL mistake, but market correction, do you agree or not?

hanera · March 9, 2021, 3:59pm

My genomics stocks are UP like crazy.

hanera · March 11, 2021, 4:28pm

Another good day.

hanera · March 16, 2021, 2:43am

.

DMTK OM TMDX

pastora · March 16, 2021, 3:02am

Nice! I’m long TMDX and DMTK. I rode the last run-up and sold but after a recent correction, I loaded heavy. I’ll go in/out though via up/down cycle. Very speculative for both so volatility will be huge. I don’t think TMDX is a 10 bagger though.

hanera · March 16, 2021, 3:30am

10-bagger is no longer exciting, so many stocks shot up by 10x over the last few years. Look for 100-baggers like AAPL AMZN TSLA.

mcp · March 16, 2021, 5:59am

friend in Apple asked me to buy more Apple shares as AR/ VR projected to be next big thing

hanera · March 16, 2021, 11:57am

Is the reason why I am buying U

hanera · March 23, 2021, 9:45pm

Blindly follow Cathie into IONS would be disastrous. Better look at the technical first. Cathie’s EW guy is not that good or Cathie over-rules him.

Screen Shot 2021-03-23 at 4.44.32 PM

Jil · March 26, 2021, 2:10am

Elt1 · March 26, 2021, 9:56am

Never buy biotech on a Monday or any other day
The analysis found that 53% of biotechs and 51% of nonbiotechs failed to maintain their IPO market value, while both groups generated similar amounts of shareholder value. … "Despite the extraordinary performance of the biotech sector in recent years, biotech is still often portrayed as a high-risk investment.Jan 7, 2021

The biotech industry tends to attract investors when it is most overvalued and scares investors when it provides the most opportunity," says Dr. Selena Chaisson, director of health care investments at Bailard, a boutique wealth and asset manager based in San Francisco.Jan 29, 2021